Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Other Operating Expenses (2022 - 2026)

Core Laboratories filings provide 5 years of Other Operating Expenses readings, the most recent being $645000.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 127.62% to $645000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $10.6 million, a 25.17% increase, with the full-year FY2025 number at $7.6 million, down 23.5% from a year prior.
  • Other Operating Expenses hit $645000.0 in Q1 2026 for Core Laboratories, down from $1.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.6 million in Q3 2025 to a low of -$2.3 million in Q1 2025.
  • Median Other Operating Expenses over the past 5 years was $864000.0 (2022), compared with a mean of $1.3 million.
  • Biggest five-year swings in Other Operating Expenses: surged 1402.44% in 2023 and later plummeted 3121.43% in 2024.
  • Core Laboratories' Other Operating Expenses stood at $660000.0 in 2022, then tumbled by 35.3% to $427000.0 in 2023, then skyrocketed by 808.67% to $3.9 million in 2024, then crashed by 64.12% to $1.4 million in 2025, then tumbled by 53.66% to $645000.0 in 2026.
  • The last three reported values for Other Operating Expenses were $645000.0 (Q1 2026), $1.4 million (Q4 2025), and $5.6 million (Q3 2025) per Business Quant data.